A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

LONDON/COPENHAGEN, April 3 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the Danish ...

Novo Nordisk (NVO) presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic injection 1 mg in adults with type 2 diabetes and early-stage symptomatic PAD1 ...

Novo Nordisk (NVO) announced updates to the Wegovy savings program, allowing all eligible cash-paying patients access to Wegovy injection 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg at their local ...